Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

KROSKROS
17 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in KEROS THERAPEUTICS INC

Yes. Qube Research & Technologies holds 608,837 shares of KROS (Keros Therapeutics), worth $6.5M, as of its Q2 2026 13F filing. It reduced the position by 116,089 shares (-16.0%) from Q1 2026. Qube Research & Technologies has held KROS since Q1 2025, across 6 quarterly 13F filings.

Current Value

$6.5M

Current Shares

608,837

Total Value Change

+$5M

Total Shares Change

+554,806

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
608,837
-16.0%
$6.5M0.0%$10.70
0
2026-Q1
Decreased
724,926
-7.5%
$8M0.0%$13.40
0
2025-Q4
Increased
783,918
+158.6%
$16M0.0%$20.27
45
2025-Q3
Increased
303,122
+683.7%
$4.8M0.0%$15.95
43
2025-Q2
Decreased
38,677
-85.8%
$516,3380.0%$13.49
0
2025-Q1
New
273,342
-
$2.8M0.0%$10.79
36
2024-Q4
Exited
0
-100.0%
$00.0%$15.64
0
2024-Q3
Decreased
27,941
-10.6%
$1.6M0.0%$56.45
0
2024-Q2
Increased
31,235
+1280.9%
$1.4M0.0%$45.70
41
2024-Q1
Decreased
2,262
-93.5%
$149,7440.0%$66.20
0
2023-Q4
Increased
34,542
+285.6%
$1.4M0.0%$39.76
41
2023-Q3
Decreased
8,958
-66.6%
$285,5810.0%$31.88
0
2023-Q2
Decreased
26,838
-28.6%
$1.1M0.0%$39.87
0
2023-Q1
Increased
37,611
+189.8%
$1.6M0.0%$42.13
41
2022-Q4
Decreased
12,980
-41.0%
$623,3000.0%$48.02
0
2022-Q3
Decreased
22,016
-59.3%
$828,0000.0%$36.31
0
2022-Q2
New
54,031
-
$1.5M0.0%$27.18
35

Other major holders of KROS: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used